Global Hospital-acquired infections (HAIs) Control Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Hospital-acquired infections (HAIs) Control will have significant change from previous year. According to our (LP Information) latest study, the global Hospital-acquired infections (HAIs) Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital-acquired infections (HAIs) Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.
The United States Hospital-acquired infections (HAIs) Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-acquired infections (HAIs) Control market, reaching US$ million by the year 2028. As for the Europe Hospital-acquired infections (HAIs) Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-acquired infections (HAIs) Control players cover STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-acquired infections (HAIs) Control market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Hospital-acquired infections (HAIs) Control will have significant change from previous year. According to our (LP Information) latest study, the global Hospital-acquired infections (HAIs) Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital-acquired infections (HAIs) Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.
The United States Hospital-acquired infections (HAIs) Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-acquired infections (HAIs) Control market, reaching US$ million by the year 2028. As for the Europe Hospital-acquired infections (HAIs) Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-acquired infections (HAIs) Control players cover STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-acquired infections (HAIs) Control market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Diagnostic techniques
- Dleaning and sterilization
- Treatment
- General Hospital
- Infectious Disease Hospital
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- STERIS Corporation
- Advanced Sterilization Products Division
- Hoffmann-La Roche
- Pfizer
- Becton Dickinson
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-acquired infections (HAIs) Control Market Size 2017-2028
2.1.2 Hospital-acquired infections (HAIs) Control Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hospital-acquired infections (HAIs) Control Segment by Type
2.2.1 Diagnostic techniques
2.2.2 Dleaning and sterilization
2.2.3 Treatment
2.3 Hospital-acquired infections (HAIs) Control Market Size by Type
2.3.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
2.4 Hospital-acquired infections (HAIs) Control Segment by Application
2.4.1 General Hospital
2.4.2 Infectious Disease Hospital
2.5 Hospital-acquired infections (HAIs) Control Market Size by Application
2.5.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
3 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SIZE BY PLAYER
3.1 Hospital-acquired infections (HAIs) Control Market Size Market Share by Players
3.1.1 Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022)
3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2020-2022)
3.2 Global Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL BY REGIONS
4.1 Hospital-acquired infections (HAIs) Control Market Size by Regions (2017-2022)
4.2 Americas Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.3 APAC Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.4 Europe Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022)
5.2 Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
5.3 Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022)
6.2 APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
6.3 APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-acquired infections (HAIs) Control by Country (2017-2022)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-acquired infections (HAIs) Control by Region (2017-2022)
8.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
8.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET FORECAST
10.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
10.1.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
10.1.2 Americas Hospital-acquired infections (HAIs) Control Forecast
10.1.3 APAC Hospital-acquired infections (HAIs) Control Forecast
10.1.4 Europe Hospital-acquired infections (HAIs) Control Forecast
10.1.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast
10.2 Americas Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
10.2.1 United States Hospital-acquired infections (HAIs) Control Market Forecast
10.2.2 Canada Hospital-acquired infections (HAIs) Control Market Forecast
10.2.3 Mexico Hospital-acquired infections (HAIs) Control Market Forecast
10.2.4 Brazil Hospital-acquired infections (HAIs) Control Market Forecast
10.3 APAC Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
10.3.1 China Hospital-acquired infections (HAIs) Control Market Forecast
10.3.2 Japan Hospital-acquired infections (HAIs) Control Market Forecast
10.3.3 Korea Hospital-acquired infections (HAIs) Control Market Forecast
10.3.4 Southeast Asia Hospital-acquired infections (HAIs) Control Market Forecast
10.3.5 India Hospital-acquired infections (HAIs) Control Market Forecast
10.3.6 Australia Hospital-acquired infections (HAIs) Control Market Forecast
10.4 Europe Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
10.4.1 Germany Hospital-acquired infections (HAIs) Control Market Forecast
10.4.2 France Hospital-acquired infections (HAIs) Control Market Forecast
10.4.3 UK Hospital-acquired infections (HAIs) Control Market Forecast
10.4.4 Italy Hospital-acquired infections (HAIs) Control Market Forecast
10.4.5 Russia Hospital-acquired infections (HAIs) Control Market Forecast
10.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
10.5.1 Egypt Hospital-acquired infections (HAIs) Control Market Forecast
10.5.2 South Africa Hospital-acquired infections (HAIs) Control Market Forecast
10.5.3 Israel Hospital-acquired infections (HAIs) Control Market Forecast
10.5.4 Turkey Hospital-acquired infections (HAIs) Control Market Forecast
10.5.5 GCC Countries Hospital-acquired infections (HAIs) Control Market Forecast
10.6 Global Hospital-acquired infections (HAIs) Control Forecast by Type (2023-2028)
10.7 Global Hospital-acquired infections (HAIs) Control Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 STERIS Corporation
11.1.1 STERIS Corporation Company Information
11.1.2 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 STERIS Corporation Main Business Overview
11.1.5 STERIS Corporation Latest Developments
11.2 Advanced Sterilization Products Division
11.2.1 Advanced Sterilization Products Division Company Information
11.2.2 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Advanced Sterilization Products Division Main Business Overview
11.2.5 Advanced Sterilization Products Division Latest Developments
11.3 Hoffmann-La Roche
11.3.1 Hoffmann-La Roche Company Information
11.3.2 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hoffmann-La Roche Main Business Overview
11.3.5 Hoffmann-La Roche Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Hospital-acquired infections (HAIs) Control Product Offered
11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Becton Dickinson
11.5.1 Becton Dickinson Company Information
11.5.2 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Becton Dickinson Main Business Overview
11.5.5 Becton Dickinson Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-acquired infections (HAIs) Control Market Size 2017-2028
2.1.2 Hospital-acquired infections (HAIs) Control Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hospital-acquired infections (HAIs) Control Segment by Type
2.2.1 Diagnostic techniques
2.2.2 Dleaning and sterilization
2.2.3 Treatment
2.3 Hospital-acquired infections (HAIs) Control Market Size by Type
2.3.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
2.4 Hospital-acquired infections (HAIs) Control Segment by Application
2.4.1 General Hospital
2.4.2 Infectious Disease Hospital
2.5 Hospital-acquired infections (HAIs) Control Market Size by Application
2.5.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
3 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SIZE BY PLAYER
3.1 Hospital-acquired infections (HAIs) Control Market Size Market Share by Players
3.1.1 Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022)
3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2020-2022)
3.2 Global Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL BY REGIONS
4.1 Hospital-acquired infections (HAIs) Control Market Size by Regions (2017-2022)
4.2 Americas Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.3 APAC Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.4 Europe Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022)
5.2 Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
5.3 Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022)
6.2 APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
6.3 APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-acquired infections (HAIs) Control by Country (2017-2022)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-acquired infections (HAIs) Control by Region (2017-2022)
8.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
8.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET FORECAST
10.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
10.1.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
10.1.2 Americas Hospital-acquired infections (HAIs) Control Forecast
10.1.3 APAC Hospital-acquired infections (HAIs) Control Forecast
10.1.4 Europe Hospital-acquired infections (HAIs) Control Forecast
10.1.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast
10.2 Americas Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
10.2.1 United States Hospital-acquired infections (HAIs) Control Market Forecast
10.2.2 Canada Hospital-acquired infections (HAIs) Control Market Forecast
10.2.3 Mexico Hospital-acquired infections (HAIs) Control Market Forecast
10.2.4 Brazil Hospital-acquired infections (HAIs) Control Market Forecast
10.3 APAC Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
10.3.1 China Hospital-acquired infections (HAIs) Control Market Forecast
10.3.2 Japan Hospital-acquired infections (HAIs) Control Market Forecast
10.3.3 Korea Hospital-acquired infections (HAIs) Control Market Forecast
10.3.4 Southeast Asia Hospital-acquired infections (HAIs) Control Market Forecast
10.3.5 India Hospital-acquired infections (HAIs) Control Market Forecast
10.3.6 Australia Hospital-acquired infections (HAIs) Control Market Forecast
10.4 Europe Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
10.4.1 Germany Hospital-acquired infections (HAIs) Control Market Forecast
10.4.2 France Hospital-acquired infections (HAIs) Control Market Forecast
10.4.3 UK Hospital-acquired infections (HAIs) Control Market Forecast
10.4.4 Italy Hospital-acquired infections (HAIs) Control Market Forecast
10.4.5 Russia Hospital-acquired infections (HAIs) Control Market Forecast
10.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
10.5.1 Egypt Hospital-acquired infections (HAIs) Control Market Forecast
10.5.2 South Africa Hospital-acquired infections (HAIs) Control Market Forecast
10.5.3 Israel Hospital-acquired infections (HAIs) Control Market Forecast
10.5.4 Turkey Hospital-acquired infections (HAIs) Control Market Forecast
10.5.5 GCC Countries Hospital-acquired infections (HAIs) Control Market Forecast
10.6 Global Hospital-acquired infections (HAIs) Control Forecast by Type (2023-2028)
10.7 Global Hospital-acquired infections (HAIs) Control Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 STERIS Corporation
11.1.1 STERIS Corporation Company Information
11.1.2 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 STERIS Corporation Main Business Overview
11.1.5 STERIS Corporation Latest Developments
11.2 Advanced Sterilization Products Division
11.2.1 Advanced Sterilization Products Division Company Information
11.2.2 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Advanced Sterilization Products Division Main Business Overview
11.2.5 Advanced Sterilization Products Division Latest Developments
11.3 Hoffmann-La Roche
11.3.1 Hoffmann-La Roche Company Information
11.3.2 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hoffmann-La Roche Main Business Overview
11.3.5 Hoffmann-La Roche Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Hospital-acquired infections (HAIs) Control Product Offered
11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Becton Dickinson
11.5.1 Becton Dickinson Company Information
11.5.2 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Becton Dickinson Main Business Overview
11.5.5 Becton Dickinson Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hospital-acquired infections (HAIs) Control Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnostic techniques
Table 3. Major Players of Dleaning and sterilization
Table 4. Major Players of Treatment
Table 5. Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 8. Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 11. Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player (2020-2022)
Table 13. Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
Table 14. Hospital-acquired infections (HAIs) Control Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-acquired infections (HAIs) Control Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Table 19. Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 21. Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 23. Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 25. APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 27. APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 29. APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 31. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 33. Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 35. Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Hospital-acquired infections (HAIs) Control
Table 44. Key Market Challenges & Risks of Hospital-acquired infections (HAIs) Control
Table 45. Key Industry Trends of Hospital-acquired infections (HAIs) Control
Table 46. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Application (2023-2028)
Table 52. STERIS Corporation Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 53. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
Table 54. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. STERIS Corporation Main Business
Table 56. STERIS Corporation Latest Developments
Table 57. Advanced Sterilization Products Division Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 58. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
Table 59. Advanced Sterilization Products Division Main Business
Table 60. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Advanced Sterilization Products Division Latest Developments
Table 62. Hoffmann-La Roche Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 63. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
Table 64. Hoffmann-La Roche Main Business
Table 65. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Hoffmann-La Roche Latest Developments
Table 67. Pfizer Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 68. Pfizer Hospital-acquired infections (HAIs) Control Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. Becton Dickinson Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 73. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
Table 74. Becton Dickinson Main Business
Table 75. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Becton Dickinson Latest Developments
Table 1. Hospital-acquired infections (HAIs) Control Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnostic techniques
Table 3. Major Players of Dleaning and sterilization
Table 4. Major Players of Treatment
Table 5. Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 8. Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 11. Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player (2020-2022)
Table 13. Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
Table 14. Hospital-acquired infections (HAIs) Control Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-acquired infections (HAIs) Control Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Table 19. Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 21. Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 23. Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 25. APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 27. APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 29. APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 31. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 33. Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 35. Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Hospital-acquired infections (HAIs) Control
Table 44. Key Market Challenges & Risks of Hospital-acquired infections (HAIs) Control
Table 45. Key Industry Trends of Hospital-acquired infections (HAIs) Control
Table 46. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Application (2023-2028)
Table 52. STERIS Corporation Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 53. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
Table 54. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. STERIS Corporation Main Business
Table 56. STERIS Corporation Latest Developments
Table 57. Advanced Sterilization Products Division Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 58. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
Table 59. Advanced Sterilization Products Division Main Business
Table 60. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Advanced Sterilization Products Division Latest Developments
Table 62. Hoffmann-La Roche Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 63. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
Table 64. Hoffmann-La Roche Main Business
Table 65. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Hoffmann-La Roche Latest Developments
Table 67. Pfizer Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 68. Pfizer Hospital-acquired infections (HAIs) Control Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. Becton Dickinson Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 73. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
Table 74. Becton Dickinson Main Business
Table 75. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Becton Dickinson Latest Developments
LIST OF FIGURES
Figure 1. Hospital-acquired infections (HAIs) Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 7. Hospital-acquired infections (HAIs) Control in General Hospital
Figure 8. Global Hospital-acquired infections (HAIs) Control Market: General Hospital (2017-2022) & ($ Millions)
Figure 9. Hospital-acquired infections (HAIs) Control in Infectious Disease Hospital
Figure 10. Global Hospital-acquired infections (HAIs) Control Market: Infectious Disease Hospital (2017-2022) & ($ Millions)
Figure 11. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player in 2021
Figure 13. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 15. APAC Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 16. Europe Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 18. Americas Hospital-acquired infections (HAIs) Control Value Market Share by Country in 2021
Figure 19. Americas Hospital-acquired infections (HAIs) Control Consumption Market Share by Type in 2021
Figure 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 21. United States Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 27. China Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2021
Figure 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 35. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 36. Germany Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 44. Egypt Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 50. APAC Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 51. Europe Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 53. United States Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 54. Canada Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 57. China Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 58. Japan Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 59. Korea Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 61. India Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 62. Australia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 63. Germany Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 64. France Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 65. UK Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 66. Italy Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 67. Russia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 68. Spain Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 71. Israel Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 1. Hospital-acquired infections (HAIs) Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 7. Hospital-acquired infections (HAIs) Control in General Hospital
Figure 8. Global Hospital-acquired infections (HAIs) Control Market: General Hospital (2017-2022) & ($ Millions)
Figure 9. Hospital-acquired infections (HAIs) Control in Infectious Disease Hospital
Figure 10. Global Hospital-acquired infections (HAIs) Control Market: Infectious Disease Hospital (2017-2022) & ($ Millions)
Figure 11. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player in 2021
Figure 13. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 15. APAC Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 16. Europe Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 18. Americas Hospital-acquired infections (HAIs) Control Value Market Share by Country in 2021
Figure 19. Americas Hospital-acquired infections (HAIs) Control Consumption Market Share by Type in 2021
Figure 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 21. United States Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 27. China Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2021
Figure 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 35. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 36. Germany Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 44. Egypt Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 50. APAC Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 51. Europe Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 53. United States Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 54. Canada Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 57. China Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 58. Japan Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 59. Korea Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 61. India Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 62. Australia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 63. Germany Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 64. France Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 65. UK Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 66. Italy Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 67. Russia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 68. Spain Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 71. Israel Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)